#COVID-19 Impacts On Therapeutic Bed Market
Explore tagged Tumblr posts
market-insider · 2 years ago
Text
Therapeutic Bed Market 2022 | Clinical Beds Product Segment Dominated Global Market
The global therapeutic bed market size is anticipated to reach USD 6.51 billion by 2030, registering a CAGR of 5.01% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic disorders, such as cancer, heart disorders, neurological disorders, kidney disorders, and others, and the growing geriatric population are the key driving factors for the market. According to the WHO, in 2020, the chronic illness prevalence increased by 57%, which is anticipated to spur market growth in the near future. The COVID-19 outbreak in 2020 increased the demand for therapeutic beds significantly.
Gain deeper insights on the market and receive your free copy with TOC now @: Therapeutic Bed Market Report
The pandemic has boosted the demand for emergency supplies, medicines, and medical equipment, such as ventilators, and hospital beds, as a result of increased hospital admissions. In addition, firms are also adopting several strategies, such as collaborations and new product launches, to help healthcare workers. For instance, in August 2020, Project C.U.R.E. received 22,500 Emergency Relief Bed (ERB) sets from Stryker. A mattress, IV pole, and bed frame were included in the ERB kits. As a result, the market is likely to grow substantially in the near future.
Furthermore, pressure injuries are a common and significant economic challenge for healthcare systems globally, costing the U.S. healthcare system more than USD 23.50 billion each year. Various manufacturers began offering solutions, such as special beds, therapeutic mattresses, and repositioning solutions, to reduce the burden of pressure injuries. Moreover, after the onset of the COVID-19 pandemic, there has been extensive demand for pressure relief beds & mattresses in hospitals and rehabilitation centers. These factors are expected to boost the market growth over the forecast period.
0 notes
gategrey9 · 4 years ago
Text
Acquire Peptides And Sarms
Revolutionising Synthetic Peptide Manufacturing
Content
Posh Colored Cuff Folding Tendrils, Pivoted Bangle, Gift Women Girl, Style Jewelry 80s, Arm Jewelry Forvalentine's Day.
Rgd Peptide.
Peptide Storage As Well As Solubilization
What Is The Difference In Between Collagen Powder And Healthy Protein Powder?
Tumblr media
The peptide synthesis can then be scaled up using the optimised series. Today, the focus of therapeutic pharmaceuticals is beginning to change far from tiny molecular medications and also in the direction of bigger, peptide based treatments.
youtube
Endocrine peptides are the proteinaceous part of the hormones produced by the glands of the endocrine system. The significant endocrine glands consist of the pineal gland, pituitary gland, pancreas, ovaries, testes, thyroid gland, parathyroid gland, hypothalamus, intestinal system and adrenal glands. Sarm - Everything You Need to Know - Sarm control a large range of bodily functions consisting of metabolism, development and development, cells function, sexual function, recreation, rest, and also mood.
Trendy Tinted Cuff Folding Tendrils, Hinged Bracelet, Present Females Lady, Fashion Jewelry 80s, Arm Fashion Jewelry Forvalentine's Day.
Making use of circulation chemistry, it is simple to pre-heat and pre-activate the amino acid. Full combining as well as deprotection cycles of simply 15 minutes are conveniently attained. This much more reliable coupling also substantially reduces the requirement for unwanteds of reagent. This decreases the expense and also amount of waste created by the synthesis. Combination of inline real-time analysis, such as UV/Vis spectroscopy and also our Variable Bed Flow Activator into the circulation after the activator permit prompt recognition of any non-standard coupling occasions. This enables the user to recognise as well as optimise difficult coupling occasions throughout tiny range syntheses.
Endogenous peptides and proteins include well identified family members of neuropeptide transmitters, neuropeptide modulators, hormones, and also fragments of useful proteins, which are necessary in several organic procedures. The peptides exert powerful organic activities in essentially all systems in the body. Activotec provides a full series of peptide synthesizers and services for peptide as well as healthy protein synthesis. If the peptide has numerous acidic amino acids, make use of an aqueous ammonia (1 to 10 %) solution, or an unpredictable basic buffer such as N-ethylmorpholine acetate or bicarbonate, with or without sonication. All products noted "keep one's cool and also completely dry" ought to be saved icy, preferably at -20 ° C. A lot of peptides, when saved below -10 ° C, will certainly stay stable for several years.
Rgd Peptide.
We are experts in peptides and have an extremely valued UK authority on peptides on our personnel and readily available through our Client Providers phone lines and e-mail. The instruments SANS2D as well as LOQ were used to make in situ measurements of the self-assembled nano-structures that developed in aqueous remedy. Changing the amino acid X bring about variants in the size and shape of the larger-scale purchasing. This implied there were different modes and degrees of beta sheet packaging, which is interesting as it might clarify how certain amino acid concepts in peptides add to disease. The data gotten utilizing SANS was enhanced by transmission electron microscopy and also atomic force microscopy information, as well as by molecular simulation.
These experiments allow Crick researchers to study thoroughly just how proteins communicate with each various other. For example, researchers utilize peptides to work out which healthy proteins repair damaged DNA. This provides understanding right into exactly how tiny particle medications which communicate with repair service healthy proteins could be utilized to treat illness such as cancer. Stac2-U-domain peptide (Air conditioning- KVDPVYETLRYGTSLALMNRSS-NH2; molecular weight 2541.9 g; purity 99%) is a cell Impenetrable inhibitor of CA2+- inactivation of Cav1.2. It is originated from the amino acid sequence og human Stac2 (deposits) and when delivered to the cytoplasm of test subject ventricular myocytes extends the heart action capacity and also recapitulates longQT syndrome.
Peptide Storage Space As Well As Solubilization
While the advantages of copper peptide are proven, in researches it is seldom compared to other peptides or various other active ingredients such as effective antioxidants. With numerous ingredients proven to profit skin, it is very important not to concentrate on a single ingredient.
What iS the best anti aging cream for over 50?
The best anti-aging creams and serums for wrinklesNeutrogena Rapid Wrinkle Repair Night Moisturizer. Olay Regenerist Micro-Sculpting Cream. Roc Retinol Correxion Deep Wrinkle Anti-Aging Retinol Night Cream. Naturopathica Argan & Retinol Wrinkle Repair Night Cream. CeraVe Skin Renewing Night Cream. More items•
Peptides are a definitely remarkable team of components that ongoing research has confirmed can profit numerous age relevant skin issues. Whether you're fighting with creases, loss of firmness, discolouration, dehydration, dullness, and so forth, there are specific peptides that can make a distinction each. Nonetheless, it truly takes a series of peptides to assist combat several skin issues, there isn't one that does every little thing. A terrific method when you've been shedding the candle light at both ends, is to utilize Patchology FlashPatch Improving Evening Eye Gels. These over night hydrogel mini sheet masks are exceptionally comfortable and also provide an effective hit of collagen improving peptides along with hyaluronic acid as well as dark circle combating arnica for noticeable renovations come morning. In the quest for ideal skin, peptides are a force to be considered. Tiny fragments of protein with the ability to tell our skin to fix and also renew itself, we reveal why you need to include them right into your anti-ageing regimen.
What Is The Difference In Between Collagen Powder As Well As Healthy Protein Powder?
You can unsubscribe at any moment by clicking on the unsubscribe web link in each newsletter. To find out more on the privacy practices of Clinique (a trading name of Estée Lauder Cosmetics Limited) your rights and how to exercise these civil liberties, please see our Privacy Policy. I would love to get information regarding Clinique items, offers, events and even more. All peptides purchased from us are synthesized by us in our laboratories. We are continuing to use full support to our customers and prepare to assist with any Covid-19 research. We have currently dealt with a number of customers on this and also are creating a full range of Sars-Cov-2 overlapping peptides along with certain ACE2 analogues.
Global Biosimilar Therapeutic Peptides Market Report 2020: COVID-19 Impacts, Growth and Changes - Forecast to 2030 - Yahoo Finance
Global Biosimilar Therapeutic Peptides Market Report 2020: COVID-19 Impacts, Growth and Changes - Forecast to 2030.
Posted: Thu, 07 Jan 2021 14:58:00 GMT [source]
This relaxing moisturiser includes 2% royal epigen, a peptide protein located in imperial jelly which is verified to enhance the rate of cell turnover for visibly smoother and much more even skin in just 28 days. Developed by Dr AJ Sturnham this rich moisturiser has a proprietary peptide mix which helps improve collagen production for firmer, more supple skin. If the peptide stays Insoluble, check out Its amino acid make-up before continuing additionally. What percentage of amino acids are hydrophobic and how many deposits are positively charged or adversely billed? If there is a web charge at neutral pH, addition of dilute acetic acid or weaken aqueous ammonia or ammonium bicarbonate with more sonication should significantly assist solubility. The last concentration of acetic acid or ammonia/ammonium bicarbonate allowed will be determined by the usage to which the peptide is to be ultimately put.
If the peptide still rejects to liquify, these unstable buffer systems might be gotten rid of by lyophilisation and alternate solvents tried on the very same peptide sample. API Provider & Chemical Development Giving services for all phases of drug development for small molecules as well as peptides. Supplying services for all phases of medicine development for little particles and peptides. On behalf of the Harley Medical Team, professional skin specialist Dr. Justine Hextall informed me that peptides can have a great deal of different applications. A combination of peptides which "trick" the skin into creating even more collagen, aiding to company, plump as well as reduce the look of great lines and also creases. A collagen revitalizing copper peptide enveloped in a polymer system which dives through the layers of the skin to specifically target collagen-producing cells.
e.g. confirmation of a cleansed protein, recognizing protein interactors from a pull-down experiment, or determining hundreds healthy proteins existing in cell line/tissue. I have discovered the initial "buffet" to do a better task in terms of hydration for my skin than this. It has a vinegar smell that dissipates as soon as it dries as well as also the uniformity is much more fluid than the initial. I usually have to apply products ahead (moisturiser + spf) when using this buffet. I would certainly suggest you try both and see which one your skin get on far better with. Keep skin-ageing at bay with The Ordinary's "Buffet" + Copper Peptides 1%; a multi-technology peptide serum that targets several indicators of ageing at the same time.
Ultimately, within our peptide family members, we have Eyelift PeptidesTM, the best lifting and firming eye treatment. With a complicated of 5 collagen-boosting peptides, this multi-action, anti-ageing eye product helps to noticeably raise as well as shape the look of eye contours for an instant well-rested, bright-eyed look. This acclaimed formula additionally harnesses the powers of hesperidin to reduce the look of dark circles, plus glycerin to moisturize the delicate eye location. Peptides might be in the limelight for their amazing collagen-boosting powers, but actually, peptides are way greater than simply a one-trick horse. Not simply for skin ageing, however also for tackling skin monotony, hyperpigmentation, anti-glycation, moisturising the skin as well as even more!
Tumblr media
Surprisingly, there is likewise research study which shows that copper is possibly toxic. However, the study focuses generally on the application of pure copper to the skin, as well as not as a peptide. The UK NEQAS Guildford Peptide Hormonal agents works in partnership with the Supra-Regional Assay Service Peptide Hormones Laboratory. Your email address will be utilized just to send you Clinique newsletters and info about Clinique products, events and also deals.
We wanted to harness the wide series of different peptide powers in our brand-new Peptide Family members. The perfect enhancement to your CSA regimen, our full variety of ingenious peptide combinations can assist to sustain various skin issues. While peptides are a natural component of skin, in their all-natural kind they are very vulnerable, unpredictable components. To stabilise and create peptides that can actually be soaked up into skin, stay intact, and also therefore have the ability to positively impact skin, they are lab-engineered. When scientific research determined exactly how to do this, the possibilities and also number of peptides readily available blew up.
Amino acids are the foundation of healthy proteins, and healthy proteins are a fundamental foundation of skin.
As a result of their function in aiding to enhance crucial healthy proteins in the skin, peptides are powerful anti-ageing components to consist of in your regimen.
They are composed of a vast range of little fragments of amino acids.
Nevertheless if peptides are not kept correctly, they can be prone to deterioration from light and air-- for instance if they are kept in containers where the product is straight subjected each time it is opened up.
By themselves, peptides belong to the body's facility communication system that informs different aspects of skin to do a much better task.
However if you're wanting to improve your routine with some hardworking, high-potency products, peptides are a good place to start.
https://provensarms.com/2020/08/02/sarms-what-can-you-expect/ have actually been drawn in by the opportunity to customize peptide sequences to introduce greater physiochemical stability and solubility. This peptide synthesis is typically adhered to by a chromatographic purification. Bespoke set vessels are often used for a medically sensible restorative peptide. The primary framework of a healthy protein is specified as the series of amino acids of which it is made up.
1 note · View note
felipeandletizia · 5 years ago
Photo
Tumblr media Tumblr media Tumblr media Tumblr media
May 8, 2020: Queen Letizia held a videoconference with the Spanish Federation of Brain Injury (FEDACE). The heads of the Spanish Federation of Brain Injury (FEDACE) today stressed to Doña Letizia the importance of starting rehabilitation activities as soon as possible so as not to continue with the loss of abilities and setbacks in the quality of life of people in need this resource. As they have explained, assistance to therapeutic day care centers fulfills two fundamental functions, on the one hand, working to improve and maintain people's capacities and, on the other hand, freeing families, caregivers, mainly women , in order that they can continue with their habitual life, in the labor, social, or any other field.
In the videoconference with Her Majesty the Queen, the President of the Spanish Federation of Brain Injury (FEDACE), Luciano Fernández Pintor, also President of the Galician Federation of Brain Injury (FEGADACE); the Vice President of FEDACE AND President of the Association of Brain Damage Coming from Castilla - La Mancha (ADACE CLM), Ana Cabellos Cano, Director of the Tutelary Foundation for Brain Damage of Castilla - La Mancha (FUNDACE CLM); and the managing director of FEDACE, Mar Barbero Lázaro, member of the National Council on Disability as an expert on the Third Sector, Disability and Employment.
FEDACE represents and energizes the Associative Movement of people with Brain Injury and their families, which brings together more than 40 territorial entities and brings together around 11,000 members. The mission of the organization is to raise awareness in society and the Administration on the importance of creating a network of social health resources and services in accordance with the number of people suffering from this brain injury and with the severity and variety of its sequelae. In the videoconference, the heads of this Federation have told him that in recent weeks "everything has taken a spectacular turnaround" since, for example, as a consequence of the confinement, all the 43 member entities of the Spanish Federation of Brain Injury (FEDACE ) have centers closed (with the exception of residences) with most of their employees teleworking; in addition, the vast majority have applied for ERTEs.
Attention to users with Brain Injury has not been possible in person and attention has been given and tele rehabilitation from computer applications in different ways: telephone monitoring especially for those who are alone, leisure activities through WhatsApp , enabling platforms to upload videos and documents with activities and exercises that users can do at home, although this proposal has led to many difficulties, since many users, as well as their family caregivers, are not adapted to new technologies and , in quite a few cases, they are lacking the necessary computer equipment (computer, wifi ...).
Likewise, a notable decrease in family calls from the hospital for cases of strokes or traumatic brain injuries -main causes of brain damage- is being appreciated, which is probably due to the fear of approaching medical centers due to the possibility of contagion. We are afraid that people have been left unattended, mainly because they have not gone to health centers. Remarkable and worrying is also the fact that, due to the need for beds, people are being sent to their homes before the end of the usual period of rehabilitation after a stroke, head trauma, brain tumor or other causes that cause Brain Damage. The loss of rehabilitation in this phase will definitely mark the recovery of people.
In the scenario of the gradual return to activities, according to those responsible for FEDACE, they warned that dysfunctions may occur is in the field of therapeutic day care centers and in the field of rehabilitation, as day centers are covered by a series of ratios both in terms of personnel and space that, at the moment, collide with what has been called social distance. On the other hand, we are talking about users with multiple pathologies and with severe degrees of dependency and disability.
This situation will also affect in a very important way the transport of people with brain damage, since, if now the volume of the chairs and the multiple pathologies of people already had a negative influence on the occupation of the media, now it will influence much more, which will imply a notable increase in the cost of the service.
Currently, the member entities of FEDACE are very concerned about their economic situation since today most of the subsidies are stopped, and even some private funders may reduce or cancel their contributions to carry out projects in favor of the people with brain damage or their families. In addition, it is very possible that this crisis affects the families of people with brain damage, with a probable family impoverishment, at an economic level.
This will also have an impact on women, who, as we have analyzed, are the ones most frequently assigned voluntarily or involuntarily as caregivers, further distancing them from the possibility of joining or rejoining the labor market.
Looking ahead, they have detailed to S.M. the Queen who will work in three fundamental directions: care for a population at greater risk than most citizens, with a series of clinical and dependency derivatives that make them much more vulnerable and that during the time the current situation has lasted Due to the lack of adequate continuity in rehabilitation, they have suffered a significant decline in their motor and cognitive state, among others; secondly, the maintenance of employment and the continuity of the entities, situations that are totally linked, with the necessary supply of protection equipment and the rest of the necessary security measures, creating, on a mandatory basis, levels of stock of materials fundamental, at least in two levels, a level 1, in the entity, for a week and a level 2, in the field of regional administration, for two weeks (21 days assured supply) and, thirdly, in the indirect administrative sphere, following the same rules as other administrations, with telework, the maintenance of security measures and the recommended distance.
The heads of the Federation indicated that where the real difficulty arises and involves a real problem is the recovery of health care and rehabilitation services, as well as the mobility of people to make these services effective.
The scope of the rehabilitation should be considered as any other clinical activity and until the full de-escalation is reached, the previous appointment should be implemented to maintain the highest levels of safety. To start the activity, the following precautions should be taken, such as carrying out the necessary tests on all personnel who provide services in the entity, such as risk personnel, as well as all persons who will use the services; guarantee the availability of hygiene and individual protection measures in centers, masks, gloves and hydrogels, as well as implement the use of electronic dispensers; restrict, as far as possible, risk activities outside the centers; increase the spatial ratio as much as possible, with activities in more open spaces or take turns providing the service to reduce the number of people present.
Regarding transportation to and from day centers, they also recalled that the multiple pathology of people with ACD makes most of them need wheelchairs that are more bulky than average to meet their needs. This implies that the occupation of space in transport vehicles is greater than the average. If we add to this the proposal / recommendation of the development authorities, it leads us to think that in an adapted 9-seater vehicle, only three chairs could go, which means a brutal increase in the cost of the service, an increase that must be paid for or families or by entities. All these measures will mean, until the normal situation is reached, a considerable increase in operating cost.
For all the above, the Spanish Federation of Brain Injury (FEDACE) proposes 12 measures and 12 challenges, from now until September, before COVID-19 to prevent situations of social injustice and socio-sanitary complications in the probable period of application.
3 notes · View notes
blueweave8 · 2 years ago
Text
Personal Care Shower and Bath Market Forecast Report, 2022-2028
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Personal Care Shower and Bath Market is projected to grow at a CAGR of 5% during the forecast period (2022-2028). The Global Personal Care Shower and Bath Market are booming predominantly due to the rising global awareness of personal health and hygiene. Consumers' living standards and disposable income are rising, so they prefer customized, expensive, aesthetic products. The demand for germ-protecting, therapeutic, and antiseptic bathing products has increased post-Covid-19 pandemic. The products with enhanced natural and organic ingredients such as seed oil, shea butter, aloe vera, tea tree, glycerin, almond oil, argan oil, fruit extracts, and vitamins are more preferred by consumers due to their therapeutic action.
Increased Usage in Hospitality Sector is Driving the Market Growth
Personal Care Shower and Bath Products have become an irreplaceable part of the hospitality sector, including resorts, hotels, lodging, inns, etc. Every guest is provided with a range of shower gel, body scrub, soap, shampoo, and conditioner. Marriott Hotels introduced their premium personal care brand, This Works, which included an amenity collection of shampoos, conditioners, bathing bars, shower gels, and shower caps to provide a luxurious and relaxing experience to their guests. To prevent infections and maintain hygiene, Vernacare Limited introduced a range of body wash products for bed washing patients, such as Foam Bath, Clinician Body Wash, and Oasis Bed Bath.
Prescence of Toxic Chemicals is Limiting the Market Growth
The use of chemicals in personal care shower and bath products is of great concern to consumers. The toxic chemicals such as formaldehyde, phthalates, phosphates, parabens, sulfates, silicones, etc., show harmful effects on the skin, such as allergic reactions and rashes. Due to these harmful effects on the skin, big players and manufacturers have decided to revolutionize this domain with natural and herbal personal care shower and bath products, due to which considerable growth is estimated in the forecast period.
Request for Sample Report @ https://www.blueweaveconsulting.com/report/personal-care-shower-and-bath-market/report-sample
Global Personal Care Shower and Bath Market - By Product Type
Based on product type, the Global Personal Care Shower and Bath Market are segmented into shower gels, liquid soap, solid soap, body scrub, bath additives, and others. Amidst the segmentation, the shower gels and liquid soap segment accounted for the largest market share in 2021 as it is an alternative to solid soaps to protect against bacteria, fungi, and viruses. Moreover, it is due to the rising demand for hair styling gel and hair-repair shampoo products that aid in treating dandruff issues. On the other hand, the body scrubs segment is expected to grow with the highest CAGR during the forecast period 2022-2028 due to its efficient skin rejuvenation property, which removes the dead skin cells to maintain smoother skin.
Global Personal Care Shower and Bath Market - Regional Insights
Based on regions, the Global Personal Care Shower and Bath Market have been segmented into five categories- North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Amidst the segmentation, North America led the Global Personal Care Shower and Bath market share in 2021 due to the rising penetration of e-commerce and social media. The demand for natural and organic products and male-oriented brands accelerated the market's growth. The Asia-Pacific is expected to grow at the highest CAGR due to the increased awareness of personal care and hygiene. The growing consumption of sustainable shower and bath care products in India and anti-dandruff shampoos and glossy hair repair conditioners in China is expected to boost the market growth.
Impact of COVID-19 on Global Personal Care Shower and Bath Market
The Global Personal Care Shower and Bath market was positively impacted during the Covid-19 pandemic. The sudden rise in infections led to an increase in usage of bathing bars, hand washes, bath gels, body washes, body scrubs, shampoos, conditioners, shower gels, etc., which led to a global upsurge in demand. As the awareness of personal care and hygiene increased, the demand for personal care shower and bath products rose, and people started stocking these products. The prominent players in this domain focused on increasing their production to meet the increasing demand for these products; for example, Henkel raised its soap supply capacity by roughly 30% globally.
Competitive Landscape
The Global Personal Care Shower and Bath Market are highly fragmented with several manufacturing companies. The key players operating in the Global Personal Care Shower and Bath Market are Unilever, Procter & Gamble, Reckitt Benckiser Group PLC, Amway, Godrej Consumer Products, Lion Corporation, GOJO Industries Inc., The Body Shop, Shiseido, 3Lab Inc., The Face Shop, L'Oreal, Colgate Palmolive Co., Natura & Co. Holding S.A., Beiersdorf AG, Johnson & Johnson, L'Artisan Parfumeur, ITC Limited, Kao Corporation, Plum Island Soap Co. and other prominent players. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, acquisitions, and partnerships to expand their customer reach and gain a competitive edge in the overall market.
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding online and offline products and services. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
0 notes
healthcaremreports · 2 years ago
Text
Therapeutic Bed Market Key Players, Industry Overview, Application and Forecast Analysis to 2022-2030
A recent market research report added to repository of Healthcare Market Reports is an in-depth analysis of global Therapeutic Bed market. On the basis of historic growth analysis and current scenario of Therapeutic Bed market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global Therapeutic Bed market. This further helps user with their developmental strategy.
This report examines all the key factors influencing growth of global Therapeutic Bed market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Therapeutic Bed market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.
Click Here to Get Free Sample Copy of Therapeutic Bed Market Report @ https://healthcaremarketreports.com/sample-request/therapeutic-bed-market/2809/?utm_source=Chaitali&utm_medium=SatPR
Global Therapeutic Bed Market: Top Key Players
Sunrise Medical
Gendron, Inc.
Invacare Corporation
Medline Industries
GF Health Products
Bakare Beds Limited
Hard Manufacturing Co.
ArjoHuntleigh
Stryker Corporation
Hill Rom, Inc.
Global Therapeutic Bed Market: By Types
Acute Care
Critical Care
Long-term
Global Therapeutic Bed Market: By Applications
Clinical
Household
Hosipital
Global Therapeutic Bed Market: By Countries
United States
Canada
Germany
UK
France
Italy
Spain
Russia
China
Japan
South Korea
Australia
Thailand
Brazil
Argentina
Chile
South Africa
Egypt
UAE
Saudi Arabia
Therapeutic Bed Market: Regional analysis includes
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
North America (the United States, Mexico, and Canada.)
South America (Brazil etc.)
The Middle East and Africa (GCC Countries and Egypt)
Some Points from Table of Contents
Chapter 1 Therapeutic Bed Introduction and Market Overview
Chapter 2 Executive Summary
Chapter 3 Industry Chain Analysis
Chapter 4 Global Therapeutic Bed Market, by Type
Chapter 5 Therapeutic Bed Market, by Application
Chapter 6 Global Therapeutic Bed Market Analysis by Regions
Chapter 7 North America Therapeutic Bed Market Analysis by Countries
Chapter 8 Europe Therapeutic Bed Market Analysis by Countries
Chapter 9 Asia Pacific Therapeutic Bed Market Analysis by Countries
Chapter 10 Middle East and Africa Therapeutic Bed Market Analysis by Countries
Chapter 11 South America Therapeutic Bed Market Analysis by Countries
Chapter 12 Competitive Landscape
Chapter 13 Industry Outlook
Chapter 14 Global Therapeutic Bed Market Forecast
Chapter 15 New Project Feasibility Analysis
Direct Purchase Therapeutic Bed Market Research Report Now @ https://healthcaremarketreports.com/purchase/therapeutic-bed-market/2809/;utm_source=Chaitali&utm_medium=SatPR
Report includes Competitor's Landscape:
➊ Major trends and growth projections by region and country ➋ Key winning strategies followed by the competitors ➌ Who are the key competitors in this industry? ➍ What shall be the potential of this industry over the forecast tenure? ➎ What are the factors propelling the demand for the Therapeutic Bed? ➏ What are the opportunities that shall aid in significant proliferation of the market growth? ➐ What are the regional and country wise regulations that shall either hamper or boost the demand for Therapeutic Bed? ➑ How has the covid-19 impacted the growth of the market? ➒ Has the supply chain disruption caused changes in the entire value chain?
Contact Us
Healthcare Market Reports 99 Wall Street 2124 New York, NY 10005 US Contact No: +1(929)-450-2887 Email: [email protected]
Thanks for reading this article you can also get individual chapter wise section or region wise report version like North America, Europe, MEA or Asia Pacific.
0 notes
latest-market-insights · 3 years ago
Text
Global Durable Medical Equipment Research Report 2022 - Industry Size, Share, Demands, Regional Analysis & Estimations Till 2028
The Global Durable Medical Equipment Market Report, in its latest update, highlights the significant impacts and the recent strategical changes under the present socio-economic scenario. The Durable Medical Equipment industry growth avenues are deeply supported by exhaustive research by the top analysts of the industry. The report starts with the executive summary, followed by a value chain and marketing channels study. The report then estimates the CAGR and market revenue of the global and regional segments.
Base Year: 2021
Estimated Year: 2022
Forecast Till: 2028
The report classifies the market into different segments based on type and product. These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels. The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.
Tumblr media
Get | Download FREE Sample Report of Global Durable Medical Equipment Market @ https://www.decisiondatabases.com/contact/download-sample-16698
A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Durable Medical Equipment market.  The impact is closely studied in terms of production, import, export, and supply.
The report covers the complete competitive landscape of the Worldwide Durable Medical Equipment market with company profiles of key players such as:
ArjoHuntleigh AB
Carex Health Brands, Inc.
Drive Medical
GF Health Products Inc.
Hill Rom, Inc
Invacare Corporation
Medline Industries, Inc.
Stryker Corporation
Sunrise Medical
Want to add more Company Profiles to the Report? Write your Customized Requirements to us @ https://www.decisiondatabases.com/contact/get-custom-research-16698
Durable Medical Equipment Market Analysis by Product:
Personal Mobility Devices
Bathroom Safety Devices And Medical Furniture
Monitoring And Therapeutic Devices
Wheelchairs
Scooters
Walker And Rollator
Cranes And Crutches
Door Openers
Other Devices
Commodes And Toilets
Mattresses & Bedding Devices
Blood Sugar Monitors
Continuous Passive Motion (CPM)
Infusion Pumps Market
Nebulizers
Oxygen Equipment
Continuous Positive Airway Pressure (CPAP)
Suction Pumps
Traction Equipment
Other Equipment
Durable Medical Equipment Market Analysis by End-Use:
Hospitals
Nursing Homes
Home Healthcare
Others
Durable Medical Equipment Market Analysis by Geography:
North America (USA, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South-East Asia, Rest of Asia-Pacific)
Latin America (Brazil, Argentina, Peru, Chile, Rest of Latin America)
The Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa, Rest of the Middle East and Africa)
Key questions answered in the report:
What is the expected growth of the Durable Medical Equipment market between 2022 to 2028?
Which application and type segment holds the maximum share in the Global Durable Medical Equipment market?
Which regional Durable Medical Equipment market shows the highest growth CAGR between 2022 to 2028?
What are the opportunities and challenges currently faced by the Durable Medical Equipment market?
Who are the leading market players and what are their Strengths, Weakness, Opportunities, and Threats (SWOT)?
What business strategies are the competitors considering to stay in the Durable Medical Equipment market?
Purchase the Complete Global Durable Medical Equipment Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-16698
About Us:
DecisionDatabases.com is a global business research report provider, enriching decision-makers, and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.
For more details: DecisionDatabases.com E-Mail: [email protected] Phone: +91 90 28 057900 Web: https://www.decisiondatabases.com/
0 notes
bhandvalkar94 · 3 years ago
Text
Global Antibiotic Resistance Market to Grow at 4% CAGR during 2021-2029
When microbes evolve biological mechanisms that can protect them from elimination by antimicrobial, the danger of antimicrobial resistance (AMR) is visible. AMR are drug-resistant pathogens whose spread is a growing public health concern in many countries. The growth of resistant bacteria usually happens due to overuse of antibiotics, or due to their use being different from what has been prescribed. This renders antibiotics less effective or ineffective. It is believed that by 2050, AMR infections may cause 10 million deaths annually. Increase in hospitalizations and increasing use of antibiotics in COVID-19 treatment are expected to further exacerbate AMR. Hence, the market for antibiotic resistance research and medicines useful for treatment is expected accelerate in the near future.
Tuberculosis (TB) is one of the most dangerous infectious diseases from a single infectious agent and its virus has developed significant antibiotic resistance in the modern times. Multidrug-resistant TB (MDR-TB) is considered a global public health emergency by the World Health Organization. According to 2017 estimates, 465,000 cases of TB were estimated worldwide. 38% people were eligible for MDR/Rifampicin-resistant (RR)-TB. 57% of MDR/RR-TB cases received successful treatment. Mylan has also secured approval from Drugs Controller General of India (DCGI) for Pretomanid, which is useful for treatment for highly drug-resistant forms of tuberculosis. Johnson & Johnson has been in the business of developing and responsibly deploying innovative technologies and treatments to combat the growing threat of AMR on multiple fronts.
Request a sample Copy@
https://www.absolutemarketsinsights.com/request_sample.php?id=876
The major factor driving the growth of global antibiotic resistance market is the growing prevalence of hospital-acquired infections. Antibiotic resistant bacteria can spread from person to person in the community. Implementing precautionary infection control procedures can minimize spread of such bacteria in hospitals. From person to person, usually this infection spreads from contact with either contaminated hands of hospital staff, or contaminated surfaces such as door handles, over-bed tables and call bells. Sometimes it also spreads due to contact with contaminated equipment that includes stethoscopes and blood pressure cuffs.
Strategic investments coupled with favorable initiatives by regulatory authorities showcases significant opportunities for the growth of global antibiotic resistance market over the period of next eight years. The Food and Drug Administration (FDA) of the United States of America (USA) and the Centers for Disease Control (CDC) in USA have launched several initiatives to help address antibiotic resistance. FDA is also encouraging new research into effective diagnostic tests, antibiotic regimens, and vaccines. Under qualified infectious disease product (QIDP) program, which is meant to encourage antibiotic development, FDA has also approved new and innovative antibiotics for resistant infections. Such antibiotics include Arikayce (amikacin liposome inhalation suspension), Baxdela (delafloxacin), Nuzyra (omadacycline), Pretomanid, Recarbrio (cilastatin, imipenem, & relebactam), Xerava (eravacycline), and Xepi (ozenoxacin).
The different variants of the coronoavirus has had severe impact on patients. Increased dosage of antibiotics are being prescribed to COVID patients who developed co-infections (bacterial with coronavirus). Increased investments into research and development initiatives towards adequate treatment of the same is anticipated to propel the growth of global antibiotic resistance market over the forecast period.
Enquiry Before Buying@
https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=876
 Key Findings of the Report:
·         The global antibiotic resistance market was valued at US$ 8417.36 Mn in 2020 growing at a CAGR of 4% over the forecast period (2021 – 2029).
·         The carbapenem-resistant enterobacteriaceae (CRE) category in the global antibiotic resistance market held the larger market share in 2020. Carbapenem-resistant enterobacteriaceae (CRE) are a family of bacteria that are very difficult to treat due to their highly resistant nature towards antibiotics. They have a reputation of adapting to different types of antibiotic treatments and develop resistance towards them.
·         The complicated urinary tract infections (cUTI) category in the global antibiotic resistance market held the larger share in 2020. Urinary tract infections (UTIs) are considered to be one of the most common types of infections. According to studies, at least one in two women and one in 10 men experience UTI in their life period.
·         Antifolates segment occupied the largest market share in the global antibiotic resistance market in 2020. Antifolate drugs are helpful in the treatment of communicable and infectious diseases such as malaria. Many bacteria and viruses that have developed antibiotic resistance spread diseases similar to malaria, such as dengue and other mosquito-borne diseases.
·         In 2020, North America dominated the global antibiotic resistance market. Availability of advanced medical sector, increasing prevalence of infectious diseases, presence of major market players, numerous drug launches in the market, and rising growth in the pharmaceutical sector amongst other factors have contributed towards the region’s highest share. Infectious Diseases Society of America (IDSA) has approved the use of many new drugs that are expected to offer successful treatment against bacteria and viruses that have developed antibiotic resistance.
·         Some of the major players operating in the global antibiotic resistance market are Allergan Pharma Co., GlaxoSmithKline PLC., Johnson & Johnson Services Inc., MELINTA THERAPEUTICS - THE ANTIBIOTICS COMPANY, Merck & Co. Inc., Mylan N.V., Nabriva Therapeutics PLC, Otsuka Novel Products GmbH, Pfizer Inc., and Sandoz AG amongst others.
Request for Customization@
https://www.absolutemarketsinsights.com/request_for_customization.php?id=876
Global Antibiotic Resistance Market:
·         By Resistant Bacteria Type
o   Pseudomonas Aeruginosa
o   Clostridioides difficile (C. difficile)
o   Carbapenem-resistant Enterobacteriaceae (CRE)
o   Streptococcus pneumoniae (S. pneumoniae)
o   Acinetobacter
o   Vancomycin-resistant Enterococci (VRE)
o   Mycobacterium Tuberculosis (TB)
o   Neisseria gonorrhoeae (N. gonorrhoeae)
o   Others
 ·         By Disease Indication
o   Complicated Urinary Tract Infections (cUTI)
o   Complicated Intra-Abdominal Infections (cIAI)
o   Community-Acquired Bacterial Pneumonia (CABP)
o   Acute Skin and Skin Structure Infections (ABSSSI)
o   Multidrug-Resistant (MDR) and Pulmonary Extensively Drug Resistant (XDR) Tuberculosis (TB) (MDR-TB and XDR-TB)
o   Sepsis
o   Clostridium Difficile (C. difficile) Infections
o   Others
 ·         By Drug Class
o   Antimycobacterials
o   Fluoroquinolones
o   Oxazolidinones
o   Tetracyclines
o   Penicillins
o   Antifolates
o   Combination Treatment
o   Others
 ·         By Route of Administration
o   Oral
o   Topical
o   Intramuscular
o   Intravenous (IV)
 ·         By End Use
o   Home Care
o   Healthcare Facilities
o   Others
 ·         By Region
o   North America
§  U.S.
§  Canada
§  Mexico
§  Rest of North America
o   Europe
§  France
§  The UK
§  Spain
§  Germany
§  Italy
§  Nordic Countries
·         Denmark
·         Finland
·         Iceland
·         Sweden
·         Norway
§  Benelux Union
·         Belgium
·         The Netherlands
·         Luxembourg
§  Rest of Europe
o   Asia Pacific
§  China
§  Japan
§  India
§  New Zealand
§  Australia
§  South Korea
§  Southeast Asia
·         Indonesia
·         Thailand
·         Malaysia
·         Singapore
·         Rest of Southeast Asia
§  Rest of Asia Pacific
o   Middle East & Africa
§  Saudi Arabia
§  UAE
§  Egypt
§  Kuwait
§  South Africa
§  Rest of Middle East & Africa
o   Latin America
§  Brazil
§  Argentina
§  Rest of Latin America
For More Information Click@ https://www.absolutemarketsinsights.com/reports/Antibiotic-Resistance-Market-2021---2029-876
About Us: Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Us:
Company: Absolute Markets Insights Email id: [email protected]  Phone: +91-740-024-2424 Contact Name: Shreyas Tanna The Work Lab,Model Colony, Shivajinagar, Pune, MH, 411016 Website: https://www.absolutemarketsinsights.com/
0 notes
fostermarketarch · 4 years ago
Text
Respiratory Devices Market Report: Analysis Of Effective Business Strategies 2021 To 2027
The global Respiratory Devices market was valued at US$ xx million in the year 2019. The market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2027, with an estimated CAGR of xx% during the forecast period (2021-2027). The research study also includes exhaustive information about market dynamics such as drivers, restraints, opportunities, technological advancements, future trends, supply chain analysis, patent landscape, pricing analysis, regulatory and reimbursement framework for precise market estimations and forecasts.
Additionally, the business intelligence study encompasses the COVID-19 scenario as follows:
·         Long-Term, Mid-Term, and Short-Term Impact of COVID-19
·         Pre- and Post-COVID-19 Scenario
·         Disruptions in the Supply Chain
Tumblr media
Get Free PDF Brochure Of This Report @ https://www.fostermarketresearch.com/product/industry/7/235/Pdf%20Brochure/
Competitive Insights
Leading and emerging companies of the global Respiratory Devices market were identified based on their current offerings. Further, the Respiratory Devices industry is one of the most competitive industries, with the leading players actively competing against each other to gain a greater share in the industry. Some of the major companies in the Respiratory Devices market are: Philips Healthcare, ResMed Inc., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Ltd., GE Healthcare, Hamilton Medical AG, ResMed Inc., Masimo Corporation, Becton and Dickinson and Company, among others.
The competitive landscape of the Respiratory Devices industry exhibits an inclination towards emerging strategies including product launches, partnerships, collaborations and contracts, acquisitions, funding, and other developments to achieve the objectives faster.
Our reports fill up the gaps and provide you with all the detailed analysis of competitive companies involving:
·         Analyzing competitive strategies and techniques
·         Competitive positioning of key players
·         PORTER’s and SWOT analysis for competitive risk analysis
·         Competitive Share Analysis
·         Financial analysis of players to determine their withstand capacity
·         Analyzing their sales path and product study
For More Information Of This Report @ https://www.fostermarketresearch.com/product/industry/7/235/
Key Segments Covered in the global Respiratory Devices market report are:
·         By Product Type: (Therapeutic Devices (Positive Airway Pressure (PAP) Devices, Ventilators, Nebulizers, Humidifiers, Oxygen Hoods, Oxygen Concentrators, Inhalers, Reusable Resuscitators), Diagnostic and Monitoring Devices (Pulse Oximeters, Capnographs, Gas Analyzers, Spirometers, Peak Flow Meters, Polysomnography (Psg) Devices), Consumers and Accessories (Masks, Breathing Circuits, Nasal Cannulas, and Others)
·         By Application: (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Allergic Rhinitis, Tuberculosis, COVID-19, and Others)
·         By End User: (Hospitals, Diagnostics Centers, Ambulance Care Centers, Home-Care Settings, and Others)        
Regional Coverage:
The global Respiratory Devices market segregates into five regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America followed by Europe held the major share of the global market (in terms of value) in 2020. However, Asia-Pacific region exhibit highest CAGR (%) during the forecast period (2021-2027). Our research study further sub-divides regions into countries as follows:
·         North America - the U.S. and Canada
·         Europe - Germany, the U.K., France, Spain, Italy, Russia, and Rest-of-Europe
·         Asia-Pacific - China, India, Japan, South Korea, Australia, ASEAN, and Rest-of-Asia-Pacific
·         Latin America - Mexico, Brazil, and Rest-of-Latin America
·         Middle East and Africa - Gulf Cooperation Council (GCC) Countries, South Africa, Israel, and Rest-of-Middle East and Africa
Market Dynamics:
The market for respiratory devices is mainly driven by infectious respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). The recent global pandemic caused by COVID-19 has come out as the main driving factor of increasing demand for respiratory devices. The increasing number of coronavirus patients around the globe has created a surge in demand of ventilators.  For, instance, in the U.S., the Javits Convention Center is converted into a hospital with nearly 2,900 beds and significant ventilators. Such rising hospitals to combat COVID-19 situation is expected to increase the demand for ventilators and consequently of respiratory devices in the market.
Apart from this, the change in the environment and lifestyle, rapid urbanization, and rise in the aged population are some factors that drive the global respiratory devices market. Moreover, the technological advances, ease of operation of devices, and increasing portability are other factors that contribute to the expansion of respiratory devices in home and alternate care settings, across the world. For instance, respiratory devices such as inhalers and nebulizers are portable, efficient and can be easily used by patients of asthma without requiring any professional assistance.  In addition, government and non-profit initiatives, such as the Global Initiative for Asthma (GINA), awareness programs, and funding research studies have influenced the industry. Currently, the challenges faced by global respiratory device market include the lack of reimbursements for various diagnostic tests and the excise tax levied on the devices. For instance, in May 2020, in the U.S. a 2.3% tax is imposed on medical devices, but recently due to global pandemic, the president has decided to repeal this law and urge the manufacturers to make more respiratory devices, to meet the current demand.
Buy Now This Business Strategic Report To Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/7/235/
About Foster Market Research:
Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data.
Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.
Contact Us:
1701 Royal Lane,
#1306, Dallas
Tx-75229
Phone: +1 469 4981929
Email:
0 notes
blueweave8 · 2 years ago
Text
Personal Care Shower and Bath Market Insight, Outlook
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Personal Care Shower and Bath Market is projected to grow at a CAGR of 5% during the forecast period (2022-2028). The Global Personal Care Shower and Bath Market are booming predominantly due to the rising global awareness of personal health and hygiene. Consumers' living standards and disposable income are rising, so they prefer customized, expensive, aesthetic products. The demand for germ-protecting, therapeutic, and antiseptic bathing products has increased post-Covid-19 pandemic. The products with enhanced natural and organic ingredients such as seed oil, shea butter, aloe vera, tea tree, glycerin, almond oil, argan oil, fruit extracts, and vitamins are more preferred by consumers due to their therapeutic action.
Increased Usage in Hospitality Sector is Driving the Market Growth
Personal Care Shower and Bath Products have become an irreplaceable part of the hospitality sector, including resorts, hotels, lodging, inns, etc. Every guest is provided with a range of shower gel, body scrub, soap, shampoo, and conditioner. Marriott Hotels introduced their premium personal care brand, This Works, which included an amenity collection of shampoos, conditioners, bathing bars, shower gels, and shower caps to provide a luxurious and relaxing experience to their guests. To prevent infections and maintain hygiene, Vernacare Limited introduced a range of body wash products for bed washing patients, such as Foam Bath, Clinician Body Wash, and Oasis Bed Bath.
Prescence of Toxic Chemicals is Limiting the Market Growth
The use of chemicals in personal care shower and bath products is of great concern to consumers. The toxic chemicals such as formaldehyde, phthalates, phosphates, parabens, sulfates, silicones, etc., show harmful effects on the skin, such as allergic reactions and rashes. Due to these harmful effects on the skin, big players and manufacturers have decided to revolutionize this domain with natural and herbal personal care shower and bath products, due to which considerable growth is estimated in the forecast period.
Request for Sample Report @ https://www.blueweaveconsulting.com/report/personal-care-shower-and-bath-market/report-sample
Global Personal Care Shower and Bath Market - By Product Type
Based on product type, the Global Personal Care Shower and Bath Market are segmented into shower gels, liquid soap, solid soap, body scrub, bath additives, and others. Amidst the segmentation, the shower gels and liquid soap segment accounted for the largest market share in 2021 as it is an alternative to solid soaps to protect against bacteria, fungi, and viruses. Moreover, it is due to the rising demand for hair styling gel and hair-repair shampoo products that aid in treating dandruff issues. On the other hand, the body scrubs segment is expected to grow with the highest CAGR during the forecast period 2022-2028 due to its efficient skin rejuvenation property, which removes the dead skin cells to maintain smoother skin.
Global Personal Care Shower and Bath Market - Regional Insights
Based on regions, the Global Personal Care Shower and Bath Market have been segmented into five categories- North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Amidst the segmentation, North America led the Global Personal Care Shower and Bath market share in 2021 due to the rising penetration of e-commerce and social media. The demand for natural and organic products and male-oriented brands accelerated the market's growth. The Asia-Pacific is expected to grow at the highest CAGR due to the increased awareness of personal care and hygiene. The growing consumption of sustainable shower and bath care products in India and anti-dandruff shampoos and glossy hair repair conditioners in China is expected to boost the market growth.
Impact of COVID-19 on Global Personal Care Shower and Bath Market
The Global Personal Care Shower and Bath market was positively impacted during the Covid-19 pandemic. The sudden rise in infections led to an increase in usage of bathing bars, hand washes, bath gels, body washes, body scrubs, shampoos, conditioners, shower gels, etc., which led to a global upsurge in demand. As the awareness of personal care and hygiene increased, the demand for personal care shower and bath products rose, and people started stocking these products. The prominent players in this domain focused on increasing their production to meet the increasing demand for these products; for example, Henkel raised its soap supply capacity by roughly 30% globally.
Competitive Landscape
The Global Personal Care Shower and Bath Market are highly fragmented with several manufacturing companies. The key players operating in the Global Personal Care Shower and Bath Market are Unilever, Procter & Gamble, Reckitt Benckiser Group PLC, Amway, Godrej Consumer Products, Lion Corporation, GOJO Industries Inc., The Body Shop, Shiseido, 3Lab Inc., The Face Shop, L'Oreal, Colgate Palmolive Co., Natura & Co. Holding S.A., Beiersdorf AG, Johnson & Johnson, L'Artisan Parfumeur, ITC Limited, Kao Corporation, Plum Island Soap Co. and other prominent players. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, acquisitions, and partnerships to expand their customer reach and gain a competitive edge in the overall market.
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding online and offline products and services. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
0 notes
market-research-future · 4 years ago
Text
Impact of COVID-19 on Healthcare Market Dynamics, Outlook And Segmentation
COVID-19 Impact on Healthcare Market Size, Trends, Growth, Dynamics and Insights By 2022
COVID-19 Impact on Healthcare Market Segmentation
The Global COVID-19 Impact on Healthcare Market Report has been covered for various sectors including medical devices/equipment, diagnostics, pharmaceuticals, technology, Healthcare IT, health insurance, medical tourism, and healthcare facilities.
The COVID-19 infection has increased the usage of masks exponentially. To meet the increasing demand for masks, many companies such as Reliance Industries Ltd. (India) have started the production of face masks in India. In early March 2020, the World Health Organization (WHO) has called to increase the production of masks by 40% to meet about 89 million mask demand per month from medical workers working in the frontline. Before the outbreak, China has manufactured more than half of the world’s masks. The corona outbreak has resulted in an increase in the production of masks to 100 million units in China and the production of N-95 masks has reached 1.6 million units. The manufacture of masks has increased by 12-fold in the country.
The diagnostics sector is further categorized into analyzers, kits & reagents, and consumables. The demand for diagnostics test kits has spiked since the past few months. Several companies have increased their production to meet the global demand. The companies are also launching new cost-effective rapid tests with low turn-around time. In April, Bione, an Indian company, launched a new screening test kit for at-home use.
The pharmaceutical is further segmented into vaccines and drugs. Several pharma companies are striving hard to advance potential therapeutics or vaccines towards the current situation. Currently, there are two candidate vaccines under Phase 1 clinical trial being developed by CanSino Biological Inc. with the Beijing Institute of Biotechnology and Moderna/NIAID. Also, there are around 42 candidate vaccines in the pre-clinical stage being developed by companies such as Inovio Pharmaceuticals, Takis/Applied DNA Sciences/Evvivax, Zydus Cadila, Sinovac, Codagenix/Serum Institute of India, and Sanofi Pasteur among others.
The product is approved by the Indian Council of Medical Research (ICMR) and displays the results in 5 to 10 minutes. The cost of these test kits is between USD 25 to USD 30. The company claims to supply 20,000 kits per week. Furthermore, in February, PCL, a South Korean IVD company has launched a testing kit, named COVID-19 Ag GICA Rapid, to detect COVID-19 with a turn-around time of 10 minutes. The test kit uses nasal discharge as a sample with an accuracy rate of around 85 percent.
The approval of any new pharmaceutical products to fight the coronavirus pandemic would be credit positive for the pharma companies involved. But the revenue opportunities for these products are difficult to estimate due to the uncertainty surrounding the severity and the duration of the pandemic, as well as other variables. These include the probability of success, the ability to scale up manufacturing, the level of competition, and product pricing, which would likely vary by region.
The Healthcare IT sector is categorized into telehealth, mHealth, ePharmacy, and EHR/EMR. Telehealth is playing a crucial role in relieving the burden of COVID-19 on hospitals. For instance, the FCC has developed and approved a USD 200 million programs to fund telehealth services and devices for medical providers. The support provided through the COVID-19 Telehealth Program will help eligible health care providers purchase telecommunications services, information services, and devices necessary to provide critical connected care services, whether for treatment of coronavirus or other health conditions during the coronavirus pandemic.
In addition to this, several startup companies are taking this opportunity to launch a new product in telehealth. For instance, Pager, a New York-based digital health startup has announced that it has developed an additional AI (artificial intelligence) feature specific to COVID-19 triage and risk assessment to its care navigation and telemedicine platform. This product is offered white-labeled to health system providers and health insurance payers. Telehealth not only caters to the need of target patients but also helps to mitigate the imbalances and shortages of healthcare professionals. Thus, new product launches, favorable government initiatives, and awareness among the population are expected to boost the application of telehealth during the COVID-19 crises.
Overview
According to MRFR analysis, the COVID-19 pandemic is expected to pose a huge impact on the overall healthcare industry. Governments and various associations in conjunction with several market players are actively participating in facing the current crisis. The key players are involved in research and development activities, strategic collaborations & partnerships, and new product launches, to cater to the current needs of vaccines, drugs, diagnostics, and medical devices such as ventilators.
The medical devices/equipment has been divided into medical ventilators, imaging devices, hospital beds, masks, personal protective equipment, sanitation, and nurse call systems. Medical ventilator Market size is expected to Witness significant growth owing to widespread use of ventilators during this COVID-19 outbreak has substantially raised the production bar of prominent players across the globe. Currently, there are about 170,000 ventilators in the US and another 12,700 in the National Strategic Supply, a cache of medical supplies maintained by the federal government to respond to national emergencies. Moreover, the prominent players are also keen on increasing their production capacities. This move has been worked out by many players, including Vyaire Medical, Hamilton Medical, and Medtronic, to sufficiently aid the medical facilities and hospital settings. The market for ventilators is expected to grow at a rate of more than 35% in the coming months as more players are manufacturing these products. In addition, the market in 2019 might not see the dominance of specific players. Furthermore, ease of regulation might increase the number of new entrants in the market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/9547
COVID-19 Impact on Healthcare Market Regional Outlook
The COVID-19 Impact on Healthcare Market has been divided, by region, into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. The US is expected to account for the largest number of COVID-19 cases followed by Spain, Italy, Germany, France, and China. The study includes the impact of COVID-19 in North America with the US, Canada, and Mexico, whereas South America is categorized into Brazil and the Rest of South America. The countries included in the European regional study include Germany, France, the UK, Italy, Spain, the Netherlands, Belgium, Switzerland, and the rest of Europe. The impact analysis also covers Asia-Pacific segmented into Japan, China, India, South Korea, Australia & New Zealand, and the rest of Asia-Pacific. The study in the Middle East & Africa has been divided into Saudi Arabia, Iran, Africa, and the Rest of MEA.
COVID-19 Impact on Healthcare Market Highlights
The COVID-19 Impact on Healthcare Market is expected to pose a significant growth by 2022, says Market Research Future (MRFR). COVID-19 outbreak has severely impacted the entire supply chain in the healthcare industry from the procurement of raw materials to production and distribution. The need for medical ventilators at a global level has triggered the manufacturers to increase production by up to 40% to 50%. The manufacturers have also collaborated with automakers to meet the growing demand. For instance, as of 30 March 2020, GE Healthcare and Ford Motors entered into a strategic partnership. As per the agreement, Ford Motors will provide its manufacturing capabilities to quickly scale production, and GE Healthcare will provide its clinical expertise and will license the current ventilator design from Airon Corporation, a US-based privately held company specializing in high-tech pneumatic life support products.
Browse More details at: https://www.marketresearchfuture.com/covid-19-analysis/covid-19-impact-healthcare-market-9547
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
0 notes
medicaldevicetech · 4 years ago
Text
Trends On Home Medical Equipment Market Size, Trends, Regional Analysis to forecast by 2025
Home medical equipment refers to devices which can provide assistance to patients within the comfort of their homes. It reduces the duration spent at the hospital and the healthcare costs of an individual. The global home medical equipment market report by Market Research Future (MRFR) takes into consideration the various drivers, challenges, and trends and its estimated growth and return rates for the period of 2019 to 2025 (forecast period). The outbreak of the COVID-19 pandemic and its impact on the industry is been discussed at length in the report.
Market Scope
The global home medical equipment market is expected to cross USD 36,189.9 million by 2025 It can reach this benchmark at a CAGR of 5.9% over the forecast period. Technological advances in home medical equipment and awareness among the populace are major factors driving market demand. The transition from conventional healthcare models to home healthcare can bode favorably for the market. Lack of hospital beds due to the outbreak of the COVID-19 pandemic has led to procurement of hospital equipment for home healthcare and will be beneficial to hospital equipment manufacturers.
Introduction of insurance policies covering home medical equipment rental costs is expected to be lucrative for market players. Prevalence of chronic diseases and rise in healthcare costs can drive people’s preference towards home healthcare.
But concerns pertaining to patient safety can hamper the market growth.
Segmentation
The global home medical equipment market has been segmented by functionality and end user.
Based on functionality, the market has been segmented into mobility assist & patient support equipment, patient monitoring equipment, and therapeutic equipment.
On the basis of end user, the market has been segmented into home care settings, emergency clinics, hospitals, and others. Hospitals are estimated to be the biggest end user of the global home medical equipment market due to increased budget for healthcare in these units, establishment of hospitals, and government initiatives for encouraging home healthcare for reducing burden on nations.
Regional Analysis
Based on the regions, the global home medical equipment market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas is the largest regional market driven by technological advancements, increasing prevalence of chronic diseases such as diabetes, cancer, etc., and preference of home care is projected to boost the market growth in this region. Moreover, presence of mobile applications for consulting with physicians from the comfort of the homes of patients can bode well for the global home medical equipment market.
Europe is expected to register a massive share of the global market due to the increasing public awareness of home medical equipment. Rise in the prevalence of chronic disorders, a sizeable patient pool, and disposable income levels are factors expected to drive the regional demand.
APAC is the fastest-growing regional market due to a surge in the number of the elderly. Susceptibility of the elderly and the lack of beds in private and public hospitals combined with the burden on the healthcare sector can drive market demand. An increasing need for affordable healthcare delivery systems is also expected to boost the adoption of home medical equipment. The growth potential in emerging economies of China, India, Malaysia, Indonesia, and Australia are expected to provide numerous opportunities for market expansion during the forecast period.
On the other hand, the MEA held the smallest market share owing to limited healthcare infrastructure and lack of awareness about home medical equipment.
Competition
GE Healthcare, Invacare Corporation, Medline Industries Incorporated, Arkray Incorporated, Philips Healthcare, Abbott, Hoffmann-La Roche Ltd, Omron Corporation, Carefusion Corporation, Stryker, Resmed Corporation, and Smiths Group PLC are key players of the global home medical equipment market.
Read More @ https://www.marketresearchfuture.com/reports/home-medical-equipment-market-8486
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:                                    
Akash Anand                                                                        
Market Research Future
+1 646 845 9312
0 notes
linhgd9 · 3 years ago
Text
Leukemia Therapeutics Market to Rise at 8.1% CAGR till 2027; Advancements in Targeted Therapies to Create Multiple Opportunities in the Market: Fortune Business Insights™
Market Overview
The global “leukemia therapeutics market” size is projected to reach USD 27.78 billion by 2027, exhibiting a CAGR of 8.1% during the forecast period. The increasing demand for enhanced treatments for blood related disease amid the COVID-19 pandemic will accelerate the market, states Fortune Business Insights
Tumblr media
in its report, titled “Leukemia Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Type of Leukemia (Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), and Others), By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Route of Administration (Oral Mode and Injectable Mode), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2027”. The demand for leukemia therapeutics has been soaring during the COVID-19 pandemic, with market players reporting increased sales. Bristol-Myers Squibb, for instance, announced that the sales of Sprycel, its treatment for chronic myeloid leukemia (CML) jumped 14% to USD 521 million in the first quarter of 2020. However, thedisruption in the medical supply chain will lead the market to register a lower growth rate of 6.2% and touch a value of USD 16.15 billion in 2020.
Request a Sample Copy of the Research Report
As per the report findings, the estimated value of the global market stood at USD 15.21 billion in 2019. The main highlights of the report include:
Calculated estimations about the upcoming trends and prospects in the market;
Path-breaking research into the regional dynamics of the market;
Comprehensive study of the factors driving and restraining the market; and
Careful profiling and diagnosis of the key market players and their dominant strategies.
Restraining Factors
Debilitating Side Effects of Chemotherapy May Hinder Market Growth
Chemotherapy is one of the most potent leukemia therapeutics and has emerged as the most powerful and the most commonly recommended. Chemo drugs are designed to attack and kill fast-growing cells, and since harmful cells proliferate rapidly, these medications speedily eliminate them. However, because chemo medicines travel throughout the body, they end up killing healthy cells, leading to side effects that can considerably weaken the patient, albeit temporarily. For example, chemotherapy can harm the blood cells in the bone marrow, where red blood cells (RBCs) are manufactured. With RBC production disrupted, the patient is likely to experience moderate to severe anemia, which in turn can cause symptoms such as fatigue, lightheadedness, and general weakness. Furthermore, chemo can also harm the production of white blood cells (WBCs), the body’s soldiers that fight infections. As a result, patients become extremely susceptible to infections and even a minor bout of cough & cold can prove detrimental for them. Thus, the known side effects of chemotherapy may hamper the leukemia therapeutics market growth.
Quick Buy Leukemia Therapeutics Market
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
The current pandemic of Covid-19 has made a catastrophic impact on the world. Most businesses are shut as a result of the increasing COVID-19 cases. The healthcare industry is facing shortage of medical aid as there are not enough beds to suffice the needs of the increasing number of patients. The world economy is fluctuating as most businesses are at a halt and the ones running from the vicinity of their homes are barely able to manage revenue.
Special reports on various markets affected by the coronavirus pandemic are provided by Fortune Business Insights. These reports will help visualize the current situation and what strategies can be adopted to help the market gain momentum in the coming years.
Click here to get the short-term and long-term impact of COVID-19 on this market.
Please visit: https://www.fortunebusinessinsights.com/leukemia-therapeutics-market-104754
Regional Insights
North America to Foster Stable Market Growth Backed by High Healthcare Expenditure
North America is expected to dominate the leukemia therapeutics market share during the forecast period as the USA and Canada have sharply increased their spending on healthcare technologies and infrastructure in the past few decades. Moreover, policymakers in the two countries are taking constant efforts to expand healthcare coverage, especially for patients. In 2019, the region’s market size stood at USD 6.92 billion.
Europe is poised to emerge as the second-largest market for leukemia therapeutics due to the increasing number of leukemia patients in the continent. In the UK, for instance, leukemia accounted for 3% of all cases in the country in 2017, according to Research UK. The market in Asia Pacific, on the other hand, will experience prolific growth owing to the improving health reimbursement policies in China and India.
Competitive Landscape
Regulatory Support for Innovative Therapies to Raise Market Potential
Key players in this market are enjoying a period of consistent support for their offerings by regulatory bodies such as the US Food and Drug Administration (FDA). Such support will play an instrumental role in managing leukemia symptoms in patients and the criticality of leukemia therapeutics is likely to rise as prevalence grows worldwide.
Have Any Query? Ask Our Experts
Industry Developments:
October 2020:The US FDA cleared AbbVie’s VENCLEXTAtreatment in combination with azacitidine, or decitabine, or low-dose cytarabine. The therapy is indicated for treating acute myeloid leukemia (AML) in adults aged 75 years and above or those with comorbidities who cannot undergo intensive chemotherapy.
September 2020: Bristol Myers Squibb secured the US FDA’s approval for its Onuregfor the continued treatment of adult patients with AML. The treatment is designed for those patients who have attained the first complete remission or remission with incomplete blood recovery following intensive chemo.
List of Key Companies Covered in this Market Report:
Sanofi/ Genzyme Corporation (Paris, France)
Hoffmann-La Roche (Basel, Switzerland)
Johnson & Johnson Services, Inc. (New Brunswick,U.S.)
Amgen Inc. (Thousand Oaks, U.S.)
Novartis (Basel, Switzerland)
Takeda Pharmaceutical Co Ltd (Tokyo, Japan)
Bristol-Myers Squibb (New York,U.S.)
AbbVie (North Chicago,U.S.)
Lupin Ltd. (India, Mumbai)
Pfizer Inc. (New York, U.S.)
Related Reports:
Digestive Health Market
Global Aesthetic Implants Market
Leukemia Therapeutics Market
Pharmacovigilance Market
Transplantation Market
About Us:
Fortune Business Insights
Tumblr media
offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights
Tumblr media
we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights
Tumblr media
Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Linkedin | Twitter | BLogs
from NeighborWebSJ https://ift.tt/2S6bZRO via IFTTT
from WordPress https://ift.tt/3wy07qM via IFTTT
0 notes
sandlerresearch · 4 years ago
Text
Pressure Relief Devices (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact) published on
https://www.sandlerresearch.org/pressure-relief-devices-wound-care-management-global-market-analysis-and-forecast-model-covid-19-market-impact.html
Pressure Relief Devices (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact)
Pressure Relief Devices (Wound Care Management) – Global Market Analysis and Forecast Model (COVID-19 market impact)
Summary
Pressure Relief Devices (Wound Care Management) – Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Wound Care Management therapeutic area.
The model discusses in detail the impact of COVID-19 on Pressure Relief Devices market for the year 2020 and beyond. Pressure ulcers are one of the leading causes for treatment requiring the use of pressure relief devices. Pressure relief devices such as mattresses, specialty beds and mattress overlays help patients by redistributing the pressure in different parts, thereby creating a balanced supply of oxygen and promoting the treatment and prevention of pressure ulcers. The primary step for the treatment and prevention of pressure ulcer is to decrease the patient’s exposure to prolonged pressure and shear.
With the use of specialized pressure-redistributing support surfaces, factors such as repositioning intervals, comfort, sleep and quality of life can be extended. Pressure relief devices enhance tissue perfusion and some support surfaces help in the management of microclimate at the interface between the patients’ skin and the support surface. Treatment is expensive due to long hospitalization periods, slow healing times, recurring wounds and an increased chance of infection.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are –
Currently marketed Pressure Relief Devices and evolving competitive landscape – – Insightful review of the key industry trends. – Annualized total Pressure Relief Devices market revenue by segment and market outlooks from 2015-2030. – Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights – – Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market. – SWOT analysis for Pressure Relief Devices market. – Competitive dynamics insights and trends provided for Pressure Relief Devices market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape. – Country specific overview of the healthcare system. – Country specific reimbursement policies. – Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: ArjoHuntleigh AB, Hill-Rom Holdings Inc, Joerns Healthcare Inc., Linet spol sro, Medline Industries Inc, Stryker Corp
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for – – CMO executives who must have deep understanding of the Pressure Relief Devices marketplace to make strategic planning and investment decisions. – Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. – Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to – – Understand the impact of COVID-19 on Pressure Relief Devices market. – Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. – Develop business strategies by understanding the trends shaping and driving Pressure Relief Devices market. – Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Pressure Relief Devices market in the future. – Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders. – Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. – Track device sales in the global and country-specific Pressure Relief Devices market from 2015-2030. – Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
0 notes
market-research-future · 4 years ago
Text
Impact of COVID-19 on Healthcare Market Analysis, Market Growth and Dynamics
According to MRFR analysis, the COVID-19 pandemic is expected to pose a huge impact on the overall healthcare industry. Governments and various associations in conjunction with several market players are actively participating in facing the current crisis. The key players are involved in research and development activities, strategic collaborations & partnerships, and new product launches, to cater to the current needs of vaccines, drugs, diagnostics, and medical devices such as ventilators.
The medical devices/equipment has been divided into medical ventilators, imaging devices, hospital beds, masks, personal protective equipment, sanitation, and nurse call systems. Medical ventilator Market size is expected to Witness significant growth owing to widespread use of ventilators during this COVID-19 outbreak has substantially raised the production bar of prominent players across the globe. Currently, there are about 170,000 ventilators in the US and another 12,700 in the National Strategic Supply, a cache of medical supplies maintained by the federal government to respond to national emergencies. Moreover, the prominent players are also keen on increasing their production capacities. This move has been worked out by many players, including Vyaire Medical, Hamilton Medical, and Medtronic, to sufficiently aid the medical facilities and hospital settings. The market for ventilators is expected to grow at a rate of more than 35% in the coming months as more players are manufacturing these products. In addition, the market in 2019 might not see the dominance of specific players. Furthermore, ease of regulation might increase the number of new entrants in the market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/9547
COVID-19 Impact on Healthcare Market Segmentation
The Global COVID-19 Impact on Healthcare Market Report has been covered for various sectors including medical devices/equipment, diagnostics, pharmaceuticals, technology, Healthcare IT, health insurance, medical tourism, and healthcare facilities.
The COVID-19 infection has increased the usage of masks exponentially. To meet the increasing demand for masks, many companies such as Reliance Industries Ltd. (India) have started the production of face masks in India. In early March 2020, the World Health Organization (WHO) has called to increase the production of masks by 40% to meet about 89 million mask demand per month from medical workers working in the frontline. Before the outbreak, China has manufactured more than half of the world’s masks. The corona outbreak has resulted in an increase in the production of masks to 100 million units in China and the production of N-95 masks has reached 1.6 million units. The manufacture of masks has increased by 12-fold in the country.
The diagnostics sector is further categorized into analyzers, kits & reagents, and consumables. The demand for diagnostics test kits has spiked since the past few months. Several companies have increased their production to meet the global demand. The companies are also launching new cost-effective rapid tests with low turn-around time. In April, Bione, an Indian company, launched a new screening test kit for at-home use.
The pharmaceutical is further segmented into vaccines and drugs. Several pharma companies are striving hard to advance potential therapeutics or vaccines towards the current situation. Currently, there are two candidate vaccines under Phase 1 clinical trial being developed by CanSino Biological Inc. with the Beijing Institute of Biotechnology and Moderna/NIAID. Also, there are around 42 candidate vaccines in the pre-clinical stage being developed by companies such as Inovio Pharmaceuticals, Takis/Applied DNA Sciences/Evvivax, Zydus Cadila, Sinovac, Codagenix/Serum Institute of India, and Sanofi Pasteur among others.
The product is approved by the Indian Council of Medical Research (ICMR) and displays the results in 5 to 10 minutes. The cost of these test kits is between USD 25 to USD 30. The company claims to supply 20,000 kits per week. Furthermore, in February, PCL, a South Korean IVD company has launched a testing kit, named COVID-19 Ag GICA Rapid, to detect COVID-19 with a turn-around time of 10 minutes. The test kit uses nasal discharge as a sample with an accuracy rate of around 85 percent.
The approval of any new pharmaceutical products to fight the coronavirus pandemic would be credit positive for the pharma companies involved. But the revenue opportunities for these products are difficult to estimate due to the uncertainty surrounding the severity and the duration of the pandemic, as well as other variables. These include the probability of success, the ability to scale up manufacturing, the level of competition, and product pricing, which would likely vary by region.
The Healthcare IT sector is categorized into telehealth, mHealth, ePharmacy, and EHR/EMR. Telehealth is playing a crucial role in relieving the burden of COVID-19 on hospitals. For instance, the FCC has developed and approved a USD 200 million programs to fund telehealth services and devices for medical providers. The support provided through the COVID-19 Telehealth Program will help eligible health care providers purchase telecommunications services, information services, and devices necessary to provide critical connected care services, whether for treatment of coronavirus or other health conditions during the coronavirus pandemic.
In addition to this, several startup companies are taking this opportunity to launch a new product in telehealth. For instance, Pager, a New York-based digital health startup has announced that it has developed an additional AI (artificial intelligence) feature specific to COVID-19 triage and risk assessment to its care navigation and telemedicine platform. This product is offered white-labeled to health system providers and health insurance payers. Telehealth not only caters to the need of target patients but also helps to mitigate the imbalances and shortages of healthcare professionals. Thus, new product launches, favorable government initiatives, and awareness among the population are expected to boost the application of telehealth during the COVID-19 crises.
COVID-19 Impact on Healthcare Market Regional Outlook
The COVID-19 Impact on Healthcare Market has been divided, by region, into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. The US is expected to account for the largest number of COVID-19 cases followed by Spain, Italy, Germany, France, and China. The study includes the impact of COVID-19 in North America with the US, Canada, and Mexico, whereas South America is categorized into Brazil and the Rest of South America. The countries included in the European regional study include Germany, France, the UK, Italy, Spain, the Netherlands, Belgium, Switzerland, and the rest of Europe. The impact analysis also covers Asia-Pacific segmented into Japan, China, India, South Korea, Australia & New Zealand, and the rest of Asia-Pacific. The study in the Middle East & Africa has been divided into Saudi Arabia, Iran, Africa, and the Rest of MEA.
COVID-19 Impact on Healthcare Market Highlights
The COVID-19 Impact on Healthcare Market is expected to pose a significant growth by 2022, says Market Research Future (MRFR). COVID-19 outbreak has severely impacted the entire supply chain in the healthcare industry from the procurement of raw materials to production and distribution. The need for medical ventilators at a global level has triggered the manufacturers to increase production by up to 40% to 50%. The manufacturers have also collaborated with automakers to meet the growing demand. For instance, as of 30 March 2020, GE Healthcare and Ford Motors entered into a strategic partnership. As per the agreement, Ford Motors will provide its manufacturing capabilities to quickly scale production, and GE Healthcare will provide its clinical expertise and will license the current ventilator design from Airon Corporation, a US-based privately held company specializing in high-tech pneumatic life support products.
Browse More details at: https://www.marketresearchfuture.com/covid-19-analysis/covid-19-impact-healthcare-market-9547
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
0 notes
market-research-future · 4 years ago
Text
Impact of COVID-19 on Healthcare Market Demand, Future Outlook And Applications Till 2022
According to MRFR analysis, the COVID-19 pandemic is expected to pose a huge impact on the overall healthcare industry. Governments and various associations in conjunction with several market players are actively participating in facing the current crisis. The key players are involved in research and development activities, strategic collaborations & partnerships, and new product launches, to cater to the current needs of vaccines, drugs, diagnostics, and medical devices such as ventilators.
COVID-19 Impact on Healthcare Market Segmentation
The Global COVID-19 Impact on Healthcare Market Report has been covered for various sectors including medical devices/equipment, diagnostics, pharmaceuticals, technology, Healthcare IT, health insurance, medical tourism, and healthcare facilities.
The COVID-19 infection has increased the usage of masks exponentially. To meet the increasing demand for masks, many companies such as Reliance Industries Ltd. (India) have started the production of face masks in India. In early March 2020, the World Health Organization (WHO) has called to increase the production of masks by 40% to meet about 89 million mask demand per month from medical workers working in the frontline. Before the outbreak, China has manufactured more than half of the world’s masks. The corona outbreak has resulted in an increase in the production of masks to 100 million units in China and the production of N-95 masks has reached 1.6 million units. The manufacture of masks has increased by 12-fold in the country.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/9547
The medical devices/equipment has been divided into medical ventilators, imaging devices, hospital beds, masks, personal protective equipment, sanitation, and nurse call systems. Medical ventilator Market size is expected to Witness significant growth owing to widespread use of ventilators during this COVID-19 outbreak has substantially raised the production bar of prominent players across the globe. Currently, there are about 170,000 ventilators in the US and another 12,700 in the National Strategic Supply, a cache of medical supplies maintained by the federal government to respond to national emergencies. Moreover, the prominent players are also keen on increasing their production capacities. This move has been worked out by many players, including Vyaire Medical, Hamilton Medical, and Medtronic, to sufficiently aid the medical facilities and hospital settings. The market for ventilators is expected to grow at a rate of more than 35% in the coming months as more players are manufacturing these products. In addition, the market in 2019 might not see the dominance of specific players. Furthermore, ease of regulation might increase the number of new entrants in the market.
The diagnostics sector is further categorized into analyzers, kits & reagents, and consumables. The demand for diagnostics test kits has spiked since the past few months. Several companies have increased their production to meet the global demand. The companies are also launching new cost-effective rapid tests with low turn-around time. In April, Bione, an Indian company, launched a new screening test kit for at-home use.
The pharmaceutical is further segmented into vaccines and drugs. Several pharma companies are striving hard to advance potential therapeutics or vaccines towards the current situation. Currently, there are two candidate vaccines under Phase 1 clinical trial being developed by CanSino Biological Inc. with the Beijing Institute of Biotechnology and Moderna/NIAID. Also, there are around 42 candidate vaccines in the pre-clinical stage being developed by companies such as Inovio Pharmaceuticals, Takis/Applied DNA Sciences/Evvivax, Zydus Cadila, Sinovac, Codagenix/Serum Institute of India, and Sanofi Pasteur among others.
The product is approved by the Indian Council of Medical Research (ICMR) and displays the results in 5 to 10 minutes. The cost of these test kits is between USD 25 to USD 30. The company claims to supply 20,000 kits per week. Furthermore, in February, PCL, a South Korean IVD company has launched a testing kit, named COVID-19 Ag GICA Rapid, to detect COVID-19 with a turn-around time of 10 minutes. The test kit uses nasal discharge as a sample with an accuracy rate of around 85 percent.
The approval of any new pharmaceutical products to fight the coronavirus pandemic would be credit positive for the pharma companies involved. But the revenue opportunities for these products are difficult to estimate due to the uncertainty surrounding the severity and the duration of the pandemic, as well as other variables. These include the probability of success, the ability to scale up manufacturing, the level of competition, and product pricing, which would likely vary by region.
The Healthcare IT sector is categorized into telehealth, mHealth, ePharmacy, and EHR/EMR. Telehealth is playing a crucial role in relieving the burden of COVID-19 on hospitals. For instance, the FCC has developed and approved a USD 200 million programs to fund telehealth services and devices for medical providers. The support provided through the COVID-19 Telehealth Program will help eligible health care providers purchase telecommunications services, information services, and devices necessary to provide critical connected care services, whether for treatment of coronavirus or other health conditions during the coronavirus pandemic.
In addition to this, several startup companies are taking this opportunity to launch a new product in telehealth. For instance, Pager, a New York-based digital health startup has announced that it has developed an additional AI (artificial intelligence) feature specific to COVID-19 triage and risk assessment to its care navigation and telemedicine platform. This product is offered white-labeled to health system providers and health insurance payers. Telehealth not only caters to the need of target patients but also helps to mitigate the imbalances and shortages of healthcare professionals. Thus, new product launches, favorable government initiatives, and awareness among the population are expected to boost the application of telehealth during the COVID-19 crises.
COVID-19 Impact on Healthcare Market Regional Outlook
The COVID-19 Impact on Healthcare Market has been divided, by region, into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. The US is expected to account for the largest number of COVID-19 cases followed by Spain, Italy, Germany, France, and China. The study includes the impact of COVID-19 in North America with the US, Canada, and Mexico, whereas South America is categorized into Brazil and the Rest of South America. The countries included in the European regional study include Germany, France, the UK, Italy, Spain, the Netherlands, Belgium, Switzerland, and the rest of Europe. The impact analysis also covers Asia-Pacific segmented into Japan, China, India, South Korea, Australia & New Zealand, and the rest of Asia-Pacific. The study in the Middle East & Africa has been divided into Saudi Arabia, Iran, Africa, and the Rest of MEA.
COVID-19 Impact on Healthcare Market Highlights
The COVID-19 Impact on Healthcare Market is expected to pose a significant growth by 2022, says Market Research Future (MRFR). COVID-19 outbreak has severely impacted the entire supply chain in the healthcare industry from the procurement of raw materials to production and distribution. The need for medical ventilators at a global level has triggered the manufacturers to increase production by up to 40% to 50%. The manufacturers have also collaborated with automakers to meet the growing demand. For instance, as of 30 March 2020, GE Healthcare and Ford Motors entered into a strategic partnership. As per the agreement, Ford Motors will provide its manufacturing capabilities to quickly scale production, and GE Healthcare will provide its clinical expertise and will license the current ventilator design from Airon Corporation, a US-based privately held company specializing in high-tech pneumatic life support products.
Browse More details at: https://www.marketresearchfuture.com/covid-19-analysis/covid-19-impact-healthcare-market-9547
Browse More Reports at:
Diabetes Market Research Report Forecast To 2023 | MRFR
Pregnancy Test Kits Market Size, Trends Analysis | Growth, 2023
Pregnancy Pillow Market Size, Growth | Share Analysis, 2023
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
0 notes